
Nanoparticles May Be the New Future for Cancer Immunotherapy
Gaurav Sharma ’22 Cancer immunotherapy has been extensively explored and requires information of the tumor’s antigen presentation in order for a method to be selected. An approach that is more effective and has a broader range had not been found that did not have the constraint of needing the information of the tumor’s antigen presentation. Researchers at Johns Hopkins School of Medicine and Johns Hopkins … Continue reading Nanoparticles May Be the New Future for Cancer Immunotherapy